Quadrant Capital Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $17.8K | Sell |
|
|||||
|
2023
Q1 | $24.4K | Hold |
|
|||||
|
2022
Q4 | $10.2K | Sell |
|
|||||
|
2022
Q3 | $7K | Sell |
|
|||||
|
2022
Q2 | $179K | Sell |
|
|||||
|
2022
Q1 | $848K | Buy |
|
|||||
|
2021
Q4 | $528K | Buy |
|
|||||
|
2021
Q3 | $1K | Hold |
|
|||||
|
2021
Q2 | $2K | Buy |
|
|||||
|
2021
Q1 | $1K | Sell |
|
|||||
|
2020
Q4 | $3K | Buy |
|
|||||
|
2020
Q3 | $1K | Sell |
|
|||||
|
2020
Q2 | $2K | Buy |
|